You have free access to this content

Hepatology

Cover image for Vol. 56 Issue 3

September 2012

Volume 56, Issue 3

Pages 793–1189

  1. Editorials

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    14. In Memorium
    15. Correction
    1. You have free access to this content
      Screening for hepatocellular carcinoma: The rationale for the American Association for the Study of Liver Diseases recommendations (pages 793–796)

      Morris Sherman, Jordi Bruix, Michael Porayko, Tram Tran and for the AASLD Practice Guidelines Committee

      Version of Record online: 30 JUL 2012 | DOI: 10.1002/hep.25869

    2. You have free access to this content
    3. You have free access to this content
  2. Viral Hepatitis

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    14. In Memorium
    15. Correction
    1. You have free access to this content
      MxA inhibits hepatitis B virus replication by interaction with hepatitis B core antigen (pages 803–811)

      Ning Li, Lei Zhang, Liangwei Chen, Wenfeng Feng, Yinfeng Xu, Feng Chen, Xiaohong Liu, Zhi Chen and Wei Liu

      Version of Record online: 2 JUL 2012 | DOI: 10.1002/hep.25608

    2. You have free access to this content
      A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearance (pages 812–819)

      Wai-Kay Seto, Danny Ka-Ho Wong, James Fung, Ivan Fan-Ngai Hung, Daniel Yee-Tak Fong, John Chi-Hang Yuen, Teresa Tong, Ching-Lung Lai and Man-Fung Yuen

      Version of Record online: 10 JUL 2012 | DOI: 10.1002/hep.25718

    3. You have free access to this content
      Transcriptomic analysis of the woodchuck model of chronic hepatitis B (pages 820–830)

      Simon P. Fletcher, Daniel J. Chin, Yongmei Ji, A. Leonardo Iniguez, Bruce Taillon, David C. Swinney, Palanikumar Ravindran, Donavan T. Cheng, Hans Bitter, Uri Lopatin, Han Ma, Klaus Klumpp and Stephan Menne

      Version of Record online: 12 JUL 2012 | DOI: 10.1002/hep.25730

    4. You have free access to this content
      Hepatitis C virus infection enhances TNFα-induced cell death via suppression of NF-κB (pages 831–840)

      Junseong Park, Wonseok Kang, Seung-Wook Ryu, Woo-Il Kim, Dong-Yeop Chang, Dong Ho Lee, Do Youn Park, Youn-Hee Choi, Kyungsun Choi, Eui-Cheol Shin and Chulhee Choi

      Version of Record online: 26 JUL 2012 | DOI: 10.1002/hep.25726

    5. You have free access to this content
      Impaired intrahepatic natural killer cell cytotoxic function in chronic hepatitis C virus infection (pages 841–849)

      Stefania Varchetta, Dalila Mele, Stefania Mantovani, Barbara Oliviero, Eleonora Cremonesi, Serena Ludovisi, Giuseppe Michelone, Mario Alessiani, Riccardo Rosati, Marco Montorsi and Mario U. Mondelli

      Version of Record online: 6 JUL 2012 | DOI: 10.1002/hep.25723

    6. You have free access to this content
      Cost-effectiveness of boceprevir or telaprevir for untreated patients with genotype 1 chronic hepatitis C (pages 850–860)

      Calogero Cammà, Salvatore Petta, Marco Enea, Raffaele Bruno, Fabrizio Bronte, Vincenza Capursi, Americo Cicchetti, Giorgio L. Colombo, Vito Di Marco, Antonio Gasbarrini, Antonio Craxì and on behalf of the WEF Study Group

      Version of Record online: 12 JUL 2012 | DOI: 10.1002/hep.25734

    7. You have free access to this content
      Efficient replication of primary or culture hepatitis C virus isolates in human liver slices: A relevant ex vivo model of liver infection (pages 861–872)

      Sylvie Lagaye, Hong Shen, Bertrand Saunier, Michelina Nascimbeni, Jesintha Gaston, Pierre Bourdoncle, Laurent Hannoun, Pierre-Philippe Massault, Anaïs Vallet-Pichard, Vincent Mallet and Stanislas Pol

      Version of Record online: 12 JUL 2012 | DOI: 10.1002/hep.25738

    8. You have free access to this content
      Foxp3+ regulatory T cells protect the liver from immune damage and compromise virus control during acute experimental hepatitis B virus infection in mice (pages 873–883)

      Leonhard Stross, Johannes Günther, Georg Gasteiger, Theresa Asen, Stefanie Graf, Michaela Aichler, Irene Esposito, Dirk H. Busch, Percy Knolle, Tim Sparwasser and Ulrike Protzer

      Version of Record online: 8 AUG 2012 | DOI: 10.1002/hep.25765

    9. You have free access to this content
      Vaniprevir with pegylated interferon alpha-2a and ribavirin in treatment-naïve patients with chronic hepatitis C: A randomized phase II study (pages 884–893)

      Michael P. Manns, Edward Gane, Maribel Rodriguez-Torres, Albrecht Stoehr, Chau-Ting Yeh, Patrick Marcellin, Richard T. Wiedmann, Peggy M. Hwang, Luzelena Caro, Richard J.O. Barnard, Andrew W. Lee and for the MK-7009 Protocol 007 Study Group

      Version of Record online: 17 JUL 2012 | DOI: 10.1002/hep.25743

  3. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    14. In Memorium
    15. Correction
    1. You have free access to this content
      Specific immunization strategies against oxidized low-density lipoprotein: A novel way to reduce nonalcoholic steatohepatitis in mice (pages 894–903)

      Veerle Bieghs, Patrick J. van Gorp, Sofie M.A. Walenbergh, Marion J. Gijbels, Fons Verheyen, Wim A. Buurman, David E. Briles, Marten H. Hofker, Christoph J. Binder and Ronit Shiri-Sverdlov

      Version of Record online: 6 JUL 2012 | DOI: 10.1002/hep.25660

    2. You have free access to this content
      Clinical cofactors and hepatic fibrosis in hereditary hemochromatosis: The role of diabetes mellitus (pages 904–911)

      Marnie J. Wood, Lawrie W. Powell, Jeannette L. Dixon and Grant A. Ramm

      Version of Record online: 19 JUN 2012 | DOI: 10.1002/hep.25720

    3. You have free access to this content
      Hydrogen-rich water prevents progression of nonalcoholic steatohepatitis and accompanying hepatocarcinogenesis in mice (pages 912–921)

      Daisuke Kawai, Akinobu Takaki, Atsuko Nakatsuka, Jun Wada, Naofumi Tamaki, Tetsuya Yasunaka, Kazuko Koike, Ryuichiro Tsuzaki, Kazuyuki Matsumoto, Yasuhiro Miyake, Hidenori Shiraha, Manabu Morita, Hirofumi Makino and Kazuhide Yamamoto

      Version of Record online: 17 JUL 2012 | DOI: 10.1002/hep.25782

    4. You have full text access to this OnlineOpen article
      Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: A randomized controlled trial (pages 922–932)

      Thuy-Anh Le, Joshua Chen, Christopher Changchien, Michael R. Peterson, Yuko Kono, Heather Patton, Benjamin L. Cohen, David Brenner, Claude Sirlin, Rohit Loomba and for the San Diego Integrated NAFLD Research Consortium (SINC)

      Version of Record online: 2 JUL 2012 | DOI: 10.1002/hep.25731

    5. You have free access to this content
    6. You have free access to this content
      Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis (pages 943–951)

      Rohit Loomba, Maria Abraham, Aynur Unalp, Laura Wilson, Joel Lavine, Ed Doo, Nathan M. Bass and the Nonalcoholic Steatohepatitis Clinical Research Network

      Version of Record online: 26 JUL 2012 | DOI: 10.1002/hep.25772

    7. You have free access to this content
      Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes (pages 952–960)

      Manal F. Abdelmalek, Mariana Lazo, Alena Horska, Susanne Bonekamp, Edward W. Lipkin, Ashok Balasubramanyam, John P. Bantle, Richard J. Johnson, Anna Mae Diehl, Jeanne M. Clark and and the Fatty Liver Subgroup of the Look AHEAD Research Group

      Version of Record online: 12 JUL 2012 | DOI: 10.1002/hep.25741

    8. You have free access to this content
  4. Hepatobiliary Malignancies

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    14. In Memorium
    15. Correction
    1. You have free access to this content
      Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma (pages 972–981)

      Sarwa Darwish Murad, W. Ray Kim, Terry Therneau, Gregory J. Gores, Charles B. Rosen, James A. Martenson, Steven R. Alberts and Julie K. Heimbach

      Version of Record online: 17 JUL 2012 | DOI: 10.1002/hep.25629

    2. You have free access to this content
      S-adenosyl methionine regulates ubiquitin-conjugating enzyme 9 protein expression and sumoylation in murine liver and human cancers (pages 982–993)

      Maria Lauda Tomasi, Ivan Tomasi, Komal Ramani, Rosa Maria Pascale, Jun Xu, Pasquale Giordano, José M. Mato and Shelly C. Lu

      Version of Record online: 12 JUL 2012 | DOI: 10.1002/hep.25701

    3. You have free access to this content
      Characteristic patterns of altered DNA methylation predict emergence of human hepatocellular carcinoma (pages 994–1003)

      Naoshi Nishida, Masatoshi Kudo, Takeshi Nagasaka, Iwao Ikai and Ajay Goel

      Version of Record online: 2 AUG 2012 | DOI: 10.1002/hep.25706

    4. You have free access to this content
      Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma (pages 1004–1014)

      Juanjuan Shan, Junjie Shen, Limei Liu, Feng Xia, Chuan Xu, Guangjie Duan, Yanmin Xu, Qinghua Ma, Zhi Yang, Qianzhen Zhang, Leina Ma, Jia Liu, Senlin Xu, Xiaochu Yan, Ping Bie, Youhong Cui, Xiu-wu Bian and Cheng Qian

      Version of Record online: 12 JUL 2012 | DOI: 10.1002/hep.25745

    5. You have free access to this content
      Hepatitis B virus X protein stabilizes amplified in breast cancer 1 protein and cooperates with it to promote human hepatocellular carcinoma cell invasiveness (pages 1015–1024)

      Yonghong Liu, Zhangwei Tong, Ting Li, Qiang Chen, Luting Zhuo, Wengang Li, Ray-Chang Wu and Chundong Yu

      Version of Record online: 2 AUG 2012 | DOI: 10.1002/hep.25751

    6. You have free access to this content
      Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model (pages 1025–1033)

      Elisa Callegari, Bahaeldin K. Elamin, Ferdinando Giannone, Maddalena Milazzo, Giuseppe Altavilla, Francesca Fornari, Luciano Giacomelli, Lucilla D'Abundo, Manuela Ferracin, Cristian Bassi, Barbara Zagatti, Fabio Corrà, Elena Miotto, Laura Lupini, Luigi Bolondi, Laura Gramantieri, Carlo M. Croce, Silvia Sabbioni and Massimo Negrini

      Version of Record online: 13 JUL 2012 | DOI: 10.1002/hep.25747

  5. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    14. In Memorium
    15. Correction
    1. You have free access to this content
      Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice (pages 1034–1043)

      Bo Kong, Li Wang, John Y.L. Chiang, Youcai Zhang, Curtis D. Klaassen and Grace L. Guo

      Version of Record online: 12 JUL 2012 | DOI: 10.1002/hep.25740

  6. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    14. In Memorium
    15. Correction
    1. You have free access to this content
      Immediate intraportal transplantation of human bone marrow mesenchymal stem cells prevents death from fulminant hepatic failure in pigs (pages 1044–1052)

      Jun Li, Liyuan Zhang, Jiaojiao Xin, Longyan Jiang, Jun Li, Ting Zhang, Linfeng Jin, Jianzhou Li, Pengcheng Zhou, Shaorui Hao, Hongcui Cao and Lanjuan Li

      Version of Record online: 12 JUL 2012 | DOI: 10.1002/hep.25722

    2. You have free access to this content
      Hepatic vein arrival time as assessed by contrast-enhanced ultrasonography is useful for the assessment of portal hypertension in compensated cirrhosis (pages 1053–1062)

      Moon Young Kim, Ki Tae Suk, Soon Koo Baik, Hyoun A. Kim, Young Ju Kim, Seung Hwan Cha, Hwa Ryun Kwak, Mee Yon Cho, Hong Jun Park, Hyo Keun Jeon, So Yeon Park, Bo Ra Kim, Jin Heon Hong, Ki Won Jo, Jae Woo Kim, Hyun Soo Kim, Sang Ok Kwon, Sei Jin Chang, Gwang Ho Baik and Dong Joon Kim

      Version of Record online: 12 JUL 2012 | DOI: 10.1002/hep.25752

  7. Liver Injury/Regeneration

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    14. In Memorium
    15. Correction
    1. You have free access to this content
      Human mesenchymal stem cells are recruited to injured liver in a β1-integrin and CD44 dependent manner (pages 1063–1073)

      Victoria Aldridge, Abhilok Garg, Nicholas Davies, David C. Bartlett, Janine Youster, Heather Beard, Dean P. Kavanagh, Neena Kalia, Jon Frampton, Patricia F. Lalor and Philip N. Newsome

      Version of Record online: 12 JUL 2012 | DOI: 10.1002/hep.25716

    2. You have free access to this content
      TIMP-1 deficiency leads to lethal partial hepatic ischemia and reperfusion injury (pages 1074–1085)

      Sergio Duarte, Takashi Hamada, Naohisa Kuriyama, Ronald W. Busuttil and Ana J. Coito

      Version of Record online: 11 JUL 2012 | DOI: 10.1002/hep.25710

    3. You have free access to this content
      Distinct contribution of human cord blood-derived endothelial colony forming cells to liver and gut in a fetal sheep model (pages 1086–1096)

      Joshua A. Wood, Evan Colletti, Laura E. Mead, David Ingram, Christopher D. Porada, Esmail D. Zanjani, Mervin C. Yoder and Graça Almeida-Porada

      Version of Record online: 2 AUG 2012 | DOI: 10.1002/hep.25753

    4. You have full text access to this OnlineOpen article
      Yes-associated protein regulates the hepatic response after bile duct ligation (pages 1097–1107)

      Haibo Bai, Nailing Zhang, Yang Xu, Qian Chen, Mehtab Khan, James J. Potter, Suresh K. Nayar, Toby Cornish, Gianfranco Alpini, Steven Bronk, Duojia Pan and Robert A. Anders

      Version of Record online: 8 AUG 2012 | DOI: 10.1002/hep.25769

  8. Liver Biology/Pathobiology

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    14. In Memorium
    15. Correction
    1. You have full text access to this OnlineOpen article
      Osteopontin is a novel downstream target of SOX9 with diagnostic implications for progression of liver fibrosis in humans (pages 1108–1116)

      James Pritchett, Emma Harvey, Varinder Athwal, Andrew Berry, Cliff Rowe, Fiona Oakley, Anna Moles, Derek A. Mann, Nicoletta Bobola, Andrew D. Sharrocks, Brian J. Thomson, Abed M. Zaitoun, William L. Irving, Indra N. Guha, Neil A. Hanley and Karen Piper Hanley

      Version of Record online: 28 AUG 2012 | DOI: 10.1002/hep.25758

    2. You have free access to this content
      Hepatic activation of IKK/NFκB signaling induces liver fibrosis via macrophage-mediated chronic inflammation (pages 1117–1128)

      Yoshiaki Sunami, Frank Leithäuser, Sarah Gul, Katja Fiedler, Nurdan Güldiken, Sigrid Espenlaub, Karl-Heinz Holzmann, Nora Hipp, Anca Sindrilaru, Tom Luedde, Bernd Baumann, Sebastian Wissel, Florian Kreppel, Marion Schneider, Karin Scharffetter-Kochanek, Stefan Kochanek, Pavel Strnad and Thomas Wirth

      Version of Record online: 10 JUL 2012 | DOI: 10.1002/hep.25711

    3. You have full text access to this OnlineOpen article
      Histone methyltransferase ASH1 orchestrates fibrogenic gene transcription during myofibroblast transdifferentiation (pages 1129–1139)

      Maria Jesus Perugorria, Caroline L. Wilson, Mujdat Zeybel, Meagan Walsh, Shilu Amin, Stuart Robinson, Steven A. White, Alastair D. Burt, Fiona Oakley, Hidekazu Tsukamoto, Derek A. Mann and Jelena Mann

      Version of Record online: 28 AUG 2012 | DOI: 10.1002/hep.25754

    4. You have free access to this content
      Cyclin E1 controls proliferation of hepatic stellate cells and is essential for liver fibrogenesis in mice (pages 1140–1149)

      Yulia A. Nevzorova, Jörg-Martin Bangen, Wei Hu, Ute Haas, Ralf Weiskirchen, Nikolaus Gassler, Sebastian Huss, Frank Tacke, Piotr Sicinski, Christian Trautwein and Christian Liedtke

      Version of Record online: 12 JUL 2012 | DOI: 10.1002/hep.25736

    5. You have free access to this content
      Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice (pages 1150–1159)

      Xiaoni Kong, Dechun Feng, Hua Wang, Feng Hong, Adeline Bertola, Fu-Sheng Wang and Bin Gao

      Version of Record online: 12 JUL 2012 | DOI: 10.1002/hep.25744

  9. Reviews

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    14. In Memorium
    15. Correction
    1. You have free access to this content
      Congenital heart disease and the liver (pages 1160–1169)

      Sumeet K. Asrani, Nina S. Asrani, Deborah K. Freese, Sabrina D. Phillips, Carole A. Warnes, Julie Heimbach and Patrick S. Kamath

      Version of Record online: 2 AUG 2012 | DOI: 10.1002/hep.25692

  10. Hepatology Elsewhere

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    14. In Memorium
    15. Correction
    1. You have free access to this content
    2. You have free access to this content
      Liver repercussions of defective gut surveillance (pages 1174–1177)

      Katharine M. Irvine, Kate Schroder and Elizabeth E. Powell

      Version of Record online: 28 AUG 2012 | DOI: 10.1002/hep.25944

  11. Clinical Observations in Hepatology

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    14. In Memorium
    15. Correction
    1. You have free access to this content
      HNF1B deficiency causes ciliary defects in human cholangiocytes (pages 1178–1181)

      Philip Roelandt, Aline Antoniou, Louis Libbrecht, Werner Van Steenbergen, Wim Laleman, Chris Verslype, Schalk Van der Merwe, Frederik Nevens, Rita De Vos, Evelyne Fischer, Marco Pontoglio, Frédéric Lemaigre and David Cassiman

      Version of Record online: 19 JUL 2012 | DOI: 10.1002/hep.25876

  12. Correspondence

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    14. In Memorium
    15. Correction
    1. You have free access to this content
      Antiannexin V antibodies: An underestimated source of noncirrhotic portal vein thrombosis? (page 1182)

      Jessy Cattelan, Evelyne Racadot, Vincent Di Martino and Thierry Thevenot

      Version of Record online: 28 AUG 2012 | DOI: 10.1002/hep.25669

    2. You have free access to this content
    3. You have free access to this content
    4. You have free access to this content
      Does reference value of “Normal Liver Stiffness” using fibroscan have a regional variation? (pages 1183–1184)

      Ramesh Kumar, Manoj Kumar Sharma and Shiv Kumar Sarin

      Version of Record online: 30 JUL 2012 | DOI: 10.1002/hep.25712

    5. You have free access to this content
    6. You have free access to this content
  13. In Memorium

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    14. In Memorium
    15. Correction
    1. You have free access to this content
      In Memoriam: Nelson Fausto, M.D. (pages 1187–1188)

      Irwin M. Arias

      Version of Record online: 30 JUL 2012 | DOI: 10.1002/hep.25974

  14. Correction

    1. Top of page
    2. Editorials
    3. Viral Hepatitis
    4. Steatohepatitis/Metabolic Liver Disease
    5. Hepatobiliary Malignancies
    6. Autoimmune, Cholestatic and Biliary Disease
    7. Liver Failure/Cirrhosis/Portal Hypertension
    8. Liver Injury/Regeneration
    9. Liver Biology/Pathobiology
    10. Reviews
    11. Hepatology Elsewhere
    12. Clinical Observations in Hepatology
    13. Correspondence
    14. In Memorium
    15. Correction
    1. You have free access to this content
      Correction (page 1189)

      Version of Record online: 28 AUG 2012 | DOI: 10.1002/hep.25885

SEARCH

SEARCH BY CITATION